Hepatitis B Vaccine
Hepatitis B DNA vaccine induces protective responses in non-responders
Published in Hepatitis Weekly, January 26th, 2004
According to recent research from the United States, "A novel DNA vaccine against hepatitis B virus was administered intra-epidermally by particle-mediated epidermal delivery (PMED) to 16 human subjects who demonstrated absent or non-sustainable responses to conventional hepatitis B vaccination. Eleven subjects received three doses of vaccine at 56-day intervals, and five subjects received only a single vaccination. Each dose of vaccine contained 4 microgram of plasmid DNA encoding the hepatitis B surface antigen (HBsAg)."
"The vaccine...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-01-26)
More Articles from Hepatitis Weekly
- Chronic Liver Disease
A new synthetic cannabinoid derivative stops inflammatory liver damage - Hepatitis A Vaccine
Virosomal hepatitis A vaccine (Epaxal) protects against infection - Hepatitis B Virus
Squamous cell carcinoma antigen 1 doesn't need serpin clearance for HBV binding - Hepatitis C Virus
HCV core protein stimulates FAS ligand expression in human liver cancer cells - Hepatitis C Virus
Peripheral blood cells may act as HCV reservoir in HIV+ hemophiliacs - Hepatitis C Virus
Pharmaceutical company expands hepatitis C virus patent portfolio - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
